Literature DB >> 25825226

The intracellular parasite Toxoplasma gondii depends on the synthesis of long-chain and very long-chain unsaturated fatty acids not supplied by the host cell.

Srinivasan Ramakrishnan1, Melissa D Docampo2, James I MacRae3, Julie E Ralton3, Thusitha Rupasinghe4, Malcolm J McConville3, Boris Striepen1,2.   

Abstract

Apicomplexa are parasitic protozoa that cause important human diseases including malaria, cryptosporidiosis and toxoplasmosis. The replication of these parasites within their target host cell is dependent on both salvage as well as de novo synthesis of fatty acids. In Toxoplasma gondii, fatty acid synthesis via the apicoplast-localized FASII is essential for pathogenesis, while the role of two other fatty acid biosynthetic complexes remains unclear. Here, we demonstrate that the ER-localized fatty acid elongation (ELO) complexes are essential for parasite growth. Conditional knockdown of the nonredundant hydroxyacyl-CoA dehydratase and enoyl-CoA reductase enzymes in the ELO pathway severely repressed intracellular parasite growth. (13) C-glucose and (13) C-acetate labeling and comprehensive lipidomic analyses of these mutants showed a selective defect in synthesis of unsaturated long and very long-chain fatty acids (LCFAs and VLCFAs) and depletion of phosphatidylinositol and phosphatidylethanolamine species containing unsaturated LCFAs and VLCFAs. This requirement for ELO pathway was bypassed by supplementing the media with specific fatty acids, indicating active but inefficient import of host fatty acids. Our experiments highlight a gap between the fatty acid needs of the parasite and availability of specific fatty acids in the host cell that the parasite has to close using a dedicated synthesis and modification pathway.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25825226      PMCID: PMC4632976          DOI: 10.1111/mmi.13010

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  39 in total

1.  Toxoplasma gondii Rab5 enhances cholesterol acquisition from host cells.

Authors:  Bruno Robibaro; Timothy T Stedman; Isabelle Coppens; Huân M Ngô; Marc Pypaert; Trevor Bivona; Hoo Woo Nam; Keith A Joiner
Journal:  Cell Microbiol       Date:  2002-03       Impact factor: 3.715

2.  High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein.

Authors:  Marc-Jan Gubbels; Catherine Li; Boris Striepen
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Atypical lipid composition in the purified relict plastid (apicoplast) of malaria parasites.

Authors:  Cyrille Y Botté; Yoshiki Yamaryo-Botté; Thusitha W T Rupasinghe; Kylie A Mullin; James I MacRae; Timothy P Spurck; Ming Kalanon; Melanie J Shears; Ross L Coppel; Paul K Crellin; Eric Maréchal; Malcolm J McConville; Geoffrey I McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

Review 4.  Current progress in the fatty acid metabolism in Cryptosporidium parvum.

Authors:  Guan Zhu
Journal:  J Eukaryot Microbiol       Date:  2004 Jul-Aug       Impact factor: 3.346

5.  Expression and functional characterization of a giant Type I fatty acid synthase (CpFAS1) gene from Cryptosporidium parvum.

Authors:  Guan Zhu; Yanan Li; Xiaomin Cai; Jason J Millership; Mary J Marchewka; Janet S Keithly
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

6.  Role of Toxoplasma gondii myosin A in powering parasite gliding and host cell invasion.

Authors:  Markus Meissner; Dirk Schlüter; Dominique Soldati
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

7.  Toxoplasma gondii exploits host low-density lipoprotein receptor-mediated endocytosis for cholesterol acquisition.

Authors:  I Coppens; A P Sinai; K A Joiner
Journal:  J Cell Biol       Date:  2000-04-03       Impact factor: 10.539

8.  Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii.

Authors:  Audra J Charron; L David Sibley
Journal:  J Cell Sci       Date:  2002-08-01       Impact factor: 5.285

9.  Toxoplasma gondii salvages sphingolipids from the host Golgi through the rerouting of selected Rab vesicles to the parasitophorous vacuole.

Authors:  Julia D Romano; Sabrina Sonda; Emily Bergbower; Maria Elisa Smith; Isabelle Coppens
Journal:  Mol Biol Cell       Date:  2013-04-24       Impact factor: 4.138

10.  BCKDH: the missing link in apicomplexan mitochondrial metabolism is required for full virulence of Toxoplasma gondii and Plasmodium berghei.

Authors:  Rebecca D Oppenheim; Darren J Creek; James I Macrae; Katarzyna K Modrzynska; Paco Pino; Julien Limenitakis; Valerie Polonais; Frank Seeber; Michael P Barrett; Oliver Billker; Malcolm J McConville; Dominique Soldati-Favre
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

View more
  22 in total

Review 1.  Vitamin and cofactor acquisition in apicomplexans: Synthesis versus salvage.

Authors:  Aarti Krishnan; Joachim Kloehn; Matteo Lunghi; Dominique Soldati-Favre
Journal:  J Biol Chem       Date:  2019-11-25       Impact factor: 5.157

2.  Identification and characterization of stearoyl-CoA desaturase in Toxoplasma gondii.

Authors:  Pan Hao; Xia Cui; Jing Liu; Muzi Li; Yong Fu; Qun Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2019-06-20       Impact factor: 3.848

3.  Transcriptomic analysis reveals Toxoplasma gondii strain-specific differences in host cell response to dense granule protein GRA15.

Authors:  Qing Liu; Wen-Wei Gao; Hany M Elsheikha; Jun-Jun He; Fa-Cai Li; Wen-Bin Yang; Xing-Quan Zhu
Journal:  Parasitol Res       Date:  2018-06-19       Impact factor: 2.289

4.  Metabolic Cooperation of Glucose and Glutamine Is Essential for the Lytic Cycle of Obligate Intracellular Parasite Toxoplasma gondii.

Authors:  Richard Nitzsche; Vyacheslav Zagoriy; Richard Lucius; Nishith Gupta
Journal:  J Biol Chem       Date:  2015-10-30       Impact factor: 5.157

5.  Novel Approaches To Kill Toxoplasma gondii by Exploiting the Uncontrolled Uptake of Unsaturated Fatty Acids and Vulnerability to Lipid Storage Inhibition of the Parasite.

Authors:  Sabrina J Nolan; Julia D Romano; John T Kline; Isabelle Coppens
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Membrane skeletal association and post-translational allosteric regulation of Toxoplasma gondii GAPDH1.

Authors:  Rashmi Dubey; Bart L Staker; Ian T Foe; Matthew Bogyo; Peter J Myler; Huân M Ngô; Marc-Jan Gubbels
Journal:  Mol Microbiol       Date:  2016-12-23       Impact factor: 3.501

7.  Acquisition of exogenous fatty acids renders apicoplast-based biosynthesis dispensable in tachyzoites of Toxoplasma.

Authors:  Xiaohan Liang; Jianmin Cui; Xuke Yang; Ningbo Xia; Yaqiong Li; Junlong Zhao; Nishith Gupta; Bang Shen
Journal:  J Biol Chem       Date:  2020-04-27       Impact factor: 5.157

8.  Toxoplasma gondii acetyl-CoA synthetase is involved in fatty acid elongation (of long fatty acid chains) during tachyzoite life stages.

Authors:  David Dubois; Stella Fernandes; Souad Amiar; Sheena Dass; Nicholas J Katris; Cyrille Y Botté; Yoshiki Yamaryo-Botté
Journal:  J Lipid Res       Date:  2018-04-20       Impact factor: 5.922

Review 9.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

10.  Apicoplast-Localized Lysophosphatidic Acid Precursor Assembly Is Required for Bulk Phospholipid Synthesis in Toxoplasma gondii and Relies on an Algal/Plant-Like Glycerol 3-Phosphate Acyltransferase.

Authors:  Souad Amiar; James I MacRae; Damien L Callahan; David Dubois; Giel G van Dooren; Melanie J Shears; Marie-France Cesbron-Delauw; Eric Maréchal; Malcolm J McConville; Geoffrey I McFadden; Yoshiki Yamaryo-Botté; Cyrille Y Botté
Journal:  PLoS Pathog       Date:  2016-08-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.